loading

Janux Therapeutics Inc Aktie (JANX) Neueste Nachrichten

pulisher
Nov 03, 2025

Is Restile Ceramics Limited Stock Discounted Enough After Recent DeclinesRSI Overbought/Oversold & Fast Profit Stock Ideas - earlytimes.in

Nov 03, 2025
pulisher
Nov 03, 2025

Can Janux Therapeutics Inc. stock surprise with earnings upsideTrade Volume Summary & Weekly Top Gainers Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Janux Therapeutics Inc. stock remains undervaluedWeekly Gains Summary & High Conviction Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Janux Therapeutics Inc. stock a safe buy before earningsWeekly Investment Recap & Weekly Breakout Stock Alerts - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Using fundamentals and technicals on Janux Therapeutics Inc.Quarterly Trade Report & Fast Moving Stock Watchlists - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What analysts say about Janux Therapeutics Inc stockTechnology Stock Trends & Turn Data into Profits With Our Strategies - earlytimes.in

Nov 02, 2025
pulisher
Nov 02, 2025

AlphaQuest LLC Has $224,000 Stock Holdings in Janux Therapeutics, Inc. $JANX - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

Is Janux Therapeutics Inc. stock attractive for income investorsJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Will Janux Therapeutics Inc. price bounce be sustainable2025 Top Decliners & Consistent Return Investment Signals - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Insider Selling: Janux Therapeutics (NASDAQ:JANX) Insider Sells 16,665 Shares of Stock - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Janux Therapeutics Inc expected to post a loss of 62 cents a shareEarnings Preview - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

Volume spikes in Janux Therapeutics Inc. stock – what they meanMarket Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Exit strategy if you’re trapped in Janux Therapeutics Inc.Quarterly Market Review & Precise Trade Entry Recommendations - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Insider Sell: Andrew Meyer Sells Shares of Janux Therapeutics In - GuruFocus

Oct 31, 2025
pulisher
Oct 30, 2025

Janux therapeutics CBO Meyer sells $500k in shares By Investing.com - Investing.com Canada

Oct 30, 2025
pulisher
Oct 29, 2025

Janux Therapeutics: The Rumor Mill Spins Up Again (NASDAQ:JANX) - Seeking Alpha

Oct 29, 2025
pulisher
Oct 29, 2025

Janux Therapeutics (JANX) Moves 8.8% Higher: Will This Strength Last? - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

Janux Therapeutics (JANX) Projected to Post Earnings on Wednesday - MarketBeat

Oct 29, 2025
pulisher
Oct 28, 2025

Janux Therapeutics (NASDAQ:JANX) Shares Up 8.6%Should You Buy? - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Exclusive BAC Article: Janux Therapeutics; 2nd Half Of 2025 JANX007 mCRPC Results Along With JANX008 In Metastatic Solid Tumors And Catalysts (NASDAQ:JANX) - Seeking Alpha

Oct 28, 2025
pulisher
Oct 28, 2025

Is Janux Therapeutics Inc. stock positioned for long term growthJuly 2025 Movers & AI Powered Trade Plan Recommendations - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 28, 2025

Janux Therapeutics stock gains amid renewed takeover speculation - Seeking Alpha

Oct 28, 2025
pulisher
Oct 28, 2025

Can Janux Therapeutics' Upcoming Immunotherapy Updates Drive A Stock Rebound? - RTTNews

Oct 28, 2025
pulisher
Oct 27, 2025

Janux Therapeutics Advances with Promising Study on JANX008 for Solid Tumor Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Janux Therapeutics Advances Prostate Cancer Study with JANX007 - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Published on: 2025-10-27 07:20:07 - newser.com

Oct 27, 2025
$37.98
price up icon 1.90%
$29.11
price up icon 1.38%
$102.23
price up icon 0.92%
$103.73
price down icon 0.22%
biotechnology ONC
$313.24
price up icon 0.57%
$184.97
price down icon 0.53%
Kapitalisierung:     |  Volumen (24h):